| Financial Year |
March 31 2022 |
| Monetary Funds |
18,020,317.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
497,500.00 |
| Accounts Receivable |
36,815,280.56 |
| Advances to Suppliers |
13,469,775.71 |
| Other Receivables |
10,057,782.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,120,602.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
86,986,712.41 |
| Total Current Assets |
182,967,970.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
53,527,841.02 |
| Investment Properties |
1,124,663.22 |
| Fixed Assetes |
89,142,146.81 |
| Under-construction Projects |
57,423,800.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,005,072.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
6,838,704.73 |
| Sub-Total of Non-Current Assets |
248,062,228.59 |
| Total Assets |
431,030,199.31 |
| Short-Term Loans |
986,368,773.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
600,000.00 |
| Accounts Payable |
124,651,966.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,136,190.75 |
| Taxes Payable |
5,729,703.66 |
| Interest Payable |
191,763,095.04 |
| Dividend Payable |
-- |
| Other payables |
960,358,327.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
500,000.00 |
| Sub-Total of Current Liabilities |
2,157,488,104.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
180,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
409,398,544.07 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
410,093,874.24 |
| Total Liabilities |
2,567,581,978.49 |
| Paid-In Capital(Or Share Stock) |
766,199,362.00 |
| Capital Surplus |
1,188,971,092.16 |
| Surplus Reserve |
17,921,326.75 |
| LESS:Treasury Stock |
71,265,363.00 |
| Undistributed Profits |
-4,062,559,633.37 |
| Minority Stockholder's Interest |
20,628,749.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,157,180,528.18 |
| Owner's Equity（Stockholder's Equity） |
-2,136,551,779.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
431,030,199.31 |
